Israel Englander Tff Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $47,939 - $85,844	-111,487 Reduced 56.67%	85,251 $40,000
Q1 2023 May 15, 2023	BUY	$0.62 - $1.1 $4,148 - $7,360	6,691 Added 3.52%	196,738 $135,000
Q4 2022 Feb 14, 2023	BUY	$0.84 - $100.75 $159,639 - $19.1 Million	190,047 New	190,047 $200,000
Q4 2021 Feb 14, 2022	SELL	$6.86 - $9.65 $359,395 - $505,563	-52,390 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.21 - $10.49 $438,901 - $638,568	-60,874 Reduced 53.75%	52,390 $404,000
Q2 2021 Aug 16, 2021	SELL	$8.48 - $13.61 $1.07 Million - $1.72 Million	-126,414 Reduced 52.74%	113,264 $1.09 Million
Q1 2021 May 17, 2021	BUY	$12.96 - $19.75 $1.78 Million - $2.71 Million	137,465 Added 134.49%	239,678 $3.25 Million
Q4 2020 Feb 16, 2021	BUY	$12.74 - $18.49 $1.3 Million - $1.89 Million	102,213 New	102,213 $1.46 Million
Q3 2020 Nov 16, 2020	SELL	$5.86 - $18.47 $116,672 - $367,737	-19,910 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.79 - $6.08 $135,958 - $218,107	-35,873 Reduced 64.31%	19,910 $115,000
Q1 2020 May 14, 2020	SELL	$3.51 - $5.36 $66 - $101	-19 Reduced 0.03%	55,783 $214,000
Q4 2019 Feb 14, 2020	BUY	$4.71 - $5.4 $262,827 - $301,330	55,802 New	55,802 $299,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.